688185.SS SHH
CanSino Biologics Inc.
1W: +28.7%
1M: +36.1%
3M: +96.0%
YTD: +56.9%
1Y: +22.6%
3Y: +27.1%
5Y: -84.7%
¥102.64 ($15.30)
+17.11 (+20.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$0
-100.0% ▼
Total Liabilities
-$4.9B
-261.8% ▼
Shareholders Equity
$4.9B
+0.4% ▲
5Y CAGR: -4.1%
Cash & Investments
$2.8B
-12.7% ▼
5Y CAGR: -11.4%
Total Debt
$0
-100.0% ▼
Net Debt
$0
-100.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5.5B | $3.4B | $2.0B | $1.6B | $0 |
| Short-Term Investments | $2.3B | $2.6B | $2.1B | $1.6B | $0 |
| Cash & ST Investments | $7.8B | $5.9B | $4.1B | $3.2B | $2.8B |
| Net Receivables | $631M | $964M | $637M | $749M | $0 |
| Inventory | $876M | $678M | $351M | $281M | $0 |
| Other Current Assets | -$379M | $0 | $61M | $13M | -$2.8B |
| Total Current Assets | $9.3B | $7.7B | $5.2B | $4.3B | $0 |
| Property, Plant & Equip. | $2.2B | $3.1B | $3.2B | $2.7B | $0 |
| Goodwill & Intangibles | $198M | $259M | $206M | $272M | $0 |
| Long-Term Investments | -$2.3B | -$2.5B | $447M | -$1.2B | $0 |
| Other Non-Current Assets | $2.4B | $2.7B | $85M | $1.7B | $0 |
| Total Non-Current Assets | $2.6B | $3.7B | $4.2B | $3.7B | $0 |
| Total Assets | $11.9B | $11.5B | $9.3B | $8.0B | $0 |
| — Liabilities — | |||||
| Accounts Payable | $843M | $253M | $104M | $62M | $0 |
| Short-Term Debt | $1.1B | $1.6B | $1.4B | $892M | $0 |
| Deferred Revenue | $193M | $1M | $0 | $0 | $0 |
| Other Current Liabilities | $727M | $474M | $144M | $443M | $0 |
| Total Current Liabilities | $2.9B | $2.9B | $2.6B | $1.8B | $0 |
| Long-Term Debt | $40M | $878M | $1.1B | $1.1B | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | -$4.9B |
| Total Non-Current Liabilities | $451M | $1.3B | $1.4B | $1.3B | -$4.9B |
| Total Liabilities | $3.3B | $4.2B | $4.0B | $3.0B | -$4.9B |
| — Equity — | |||||
| Common Stock | $247M | $247M | $247M | $247M | $0 |
| Retained Earnings | $1.0B | -$76M | -$1.6B | -$1.9B | $0 |
| Accumulated OCI | $160M | $171M | -$176K | $27M | $4.9B |
| Total Stockholders Equity | $8.0B | $6.7B | $5.3B | $4.9B | $4.9B |
| Total Liabilities & Equity | $11.9B | $11.5B | $9.3B | $8.0B | $0 |
| — Key Metrics — | |||||
| Total Debt | $1.4B | $2.7B | $2.7B | $2.0B | $0 |
| Net Debt | -$4.1B | -$694M | $653M | $457M | $0 |
| Total Investments | $45M | $50M | $2.5B | $484M | $0 |